India's Drug Regulator Reviews Use of High-Risk Solvents in Paediatric Cough Syrups
2 hours agoPolitics
53LENS
2 SourcesIndia
TBNthebalanced.news

India's Drug Regulator Reviews Use of High-Risk Solvents in Paediatric Cough Syrups

Following multiple child deaths linked to contaminated cough syrups, India's drug regulator, CDSCO, has initiated consultations with the pharmaceutical industry to review the use of high-risk solvents like propylene glycol and its toxic impurities diethylene glycol (DEG) and ethylene glycol (EG) in paediatric oral liquid formulations. The Drugs Consultative Committee has highlighted safety concerns and is considering regulatory guidelines and safer alternatives to prevent further contamination risks in syrups and drops intended for children.

Political Bias
15%80%5%
Sentiment
38%
AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 13 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 2 sources
● Left 15%● Center 80%● Right 5%

The articles present a regulatory and public health perspective without evident political framing. They focus on government agencies' actions and expert committee deliberations, reflecting concerns over pharmaceutical safety. The coverage includes official statements and industry consultations, representing institutional viewpoints rather than partisan or ideological positions.

Sentiment — Neutral (38/100)

The tone across the articles is cautious and serious, emphasizing safety risks and regulatory responses following tragic incidents. While the coverage highlights concerns and past fatalities, it maintains a neutral and factual approach, focusing on ongoing efforts to address the issue rather than assigning blame or expressing optimism.

How 2 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
economictimesDrug regulator drafts guidelines on high-risk solvents after tainted syrup deaths in kidsCenterNeutral
news18Drug Regulator To Meet Pharma Industry To Review High-Risk Solvents In Cough SyrupsCenterNeutral

Coverage timeline

news18 broke this story on 13 May, 02:31 am. Other outlets followed.

  1. 1
    news1813 May, 02:31 am
    Drug Regulator To Meet Pharma Industry To Review High-Risk Solvents In Cough Syrups
  2. 2
    economictimes13 May, 07:13 pm
    Drug regulator drafts guidelines on high-risk solvents after tainted syrup deaths in kids

Lens Score breakdown

53/100
Public interest32/100
Coverage gap100%

Moderately important story that could benefit from broader coverage.

Accountability flags

TBN's analysis identified the following accountability dimensions in this story.

  • systemic failure

    This story points to a failure in institutional processes — regulation, safety, oversight, or service delivery breaking down at scale.

  • public safety issue

    This story involves a risk to public safety — infrastructure failure, regulatory lapse, hazardous conditions, or emergency mishandling.

Who's involved

Institutions and figures named across source coverage.

Government
Central Drugs Standard Control OrganizationCentral Drugs Standard Control OrganisationMadhya Pradesh State GovernmentDrugs Controller General of IndiaDrugs Consultative Committee
Corporate
Sresan PharmaceuticalsShape PharmaRednex PharmaceuticalsKayson Pharma

Story context

Category
Politics
Location
India
Sources analysed
2
Last analysed
13 May 2026
Key entities
Cold medicineSolventSyrupIndiaExcipientEgyptEthylene glycolMadhya PradeshPropyleneNew DelhiRajasthanCentral Drugs Standard Control Organisation